The Product
MammoRisk+ is a proprietary AI model trained on real-world mammography data to predict future breast cancer risk.
The platform enables:
-
Automated risk stratification
-
Integration into screening workflows
-
Deployment across multi-site healthcare systems
-
Scalable cloud-based processing
Designed for responsible clinical adoption and large-scale implementation.
How It Works
How the Platform Works
-
Mammogram data securely uploaded
-
AI model processes imaging features
-
Risk score generated
-
Structured output for clinical decision support
Built for integration into existing digital health infrastructures.
Bussiness Model
ALIA Health operates under a B2B licensing model focused on healthcare institutions and screening programs.
• Institutional licensing
• Pilot deployments in clinical environments
• Integration within existing imaging workflows
• Scalable cloud-based infrastructure
Our goal is to enable risk-adapted, data-driven screening strategies at population scale.
Technology & Infrastructure
"Cloud-Native Architecture"
ALIA Health is built on scalable cloud infrastructure designed for secure, multi-site deployment across healthcare systems. We support high-volume image processing and enterprise-level integration.
Daly Avendaño, MD, PhD
Co-Founder & Chief Medical Director
FOUNDING TEAM
José Tamez Peña, PhD
Co-Founder & Head of AI Research
Servando Cardona Huerta, MD, PhD
Co-Founder & Clinical Strategy Lead
Ready to deploy AI-driven risk prediction?
Request information about pilot deployment, enterprise licensing, or strategic partnerships.
We are currently engaging with healthcare institutions and early-stage investors.
FOLLOW US!
